TOPADUR Pharma AG is a biopharmaceutical start-up company located at the successful Bio-Technopark in Schlieren-Zürich, Switzerland (www.topadur.com). The company was established in April 2015.
The company focusses on the discovery and the development of innovative LMW drugs for wound healing in conditions with highly unmet medical need such as Diabetic Foot Ulcer and corneal wound healing. Additionally, the invention of new mode of action drugs resulted in unique drug candidates outside wound healing indications such as colorectal cancer, cancer stem cell elimination, glaucoma and medical cosmetics. The company gathered not only specialists and experts from these fields, but its management team has many years of experience in developing pharmaceuticals in the most feasible way in terms of speed and quality.
The company focusses on the discovery and the development of innovative LMW drugs for wound healing in conditions with highly unmet medical need such as Diabetic Foot Ulcer and corneal wound healing. Additionally, the invention of new mode of action drugs resulted in unique drug candidates outside wound healing indications such as colorectal cancer, cancer stem cell elimination, glaucoma and medical cosmetics. The company gathered not only specialists and experts from these fields, but its management team has many years of experience in developing pharmaceuticals in the most feasible way in terms of speed and quality.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Switzerland
Year Founded:
2015
Main Therapeutic Focus:
Regenerative Medicine
Lead Product in Development:
TOP-N53
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Five
Speaker
